GSK’s US$750 million cancer drug deal highlights China’s rise as biotech player
Direct Source Verification:
This story is aggregated from South China Morning Post (scmp.com). Full reporting rights and copyright belong to the primary publisher.
GSK’s US$750 million cancer drug deal highlights China’s rise as biotech player scmp.com
Original Source
https://news.google.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?oc=5
